Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2024
New study shows NICE advice support can reduce appraisal timelines by 3 months
14 November 2024 - Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance ...
Posted by Michael Wonder on 07 Oct 2024
New flexible service through our scientific advice program
26 September 2024 - Drug sponsors can now request a flexible service through our scientific advice program that can include ...
Posted by Michael Wonder on 27 Jun 2024
Expanding our scientific advice services for the life sciences sector in Canada
26 June 2024 - Canada’s Drug Agency is launching a new one year learning period in our Scientific Advice program ...
Posted by Michael Wonder on 03 Jul 2023
EU-HTA: G-BA coordinates parallel scientific consultations for manufacturers from September
3 July 2023 - From 2025, a systematic evaluation of clinical studies for new medicinal products and medical devices will ...
Posted by Michael Wonder on 15 Mar 2023
EMA-FDA parallel scientific advice program has ‘limited’ uptake
14 March 2023 - A review of the last five years of the parallel scientific advice program between the FDA ...
Posted by Michael Wonder on 27 Feb 2023
EMA pilots scientific advice for certain high risk medical devices
27 February 2023 - The EMA has launched a pilot to give scientific advice on the intended clinical development strategy ...
Posted by Michael Wonder on 12 May 2022
CADTH expands scientific advice program to include advice on real world evidence
28 April 2022 - CADTH is expanding its scientific advice program to include applications for advice on real world evidence generation ...
Posted by Michael Wonder on 07 Oct 2020
New online platform for scientific advice
7 October 2020 - From 19 October 2020, developers of human or veterinary medicines should use EMA’s IRIS Regulatory & ...
Posted by Michael Wonder on 22 Sep 2020
New early scientific advice service to support medicine registrations
22 September 2020 - The Therapeutic Goods Administration has launched a new initiative - the Early Scientific Advice service - ...
Posted by Michael Wonder on 23 Jun 2020
Academia developing medicines for rare diseases to receive free EMA scientific advice
23 June 2020 - To further encourage the development of treatments for rare diseases, EMA will waive all fees for ...
Posted by Michael Wonder on 14 Mar 2020
COVID-19: developers of medicines or vaccines to benefit from free scientific advice
13 March 2020 - EMA provides full fee waivers for scientific advice applications from developers of potential therapeutics (to treat ...
Posted by Michael Wonder on 02 Mar 2019
Health Canada and CADTH launch new initiative to provide early parallel scientific advice
1 March 2019 - CADTH is pleased to announce a new collaboration with Health Canada and the Institut national d'excellence en ...
Posted by Michael Wonder on 14 Feb 2019
NICE provides first scientific advice on patient preference study design
14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...
Posted by Michael Wonder on 06 Feb 2019
NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice
6 February 2019 - NICE and the Canadian Agency for Drugs and Technology in Health have launched a new collaboration to ...
Posted by Michael Wonder on 06 Feb 2019
New opportunity: parallel scientific advice from CADTH and NICE
6 February 2019 - CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and ...